.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Express Scripts
Queensland Health
Farmers Insurance
Johnson and Johnson
Fuji
Citi
Cantor Fitzgerald
Covington
AstraZeneca

Generated: December 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074286

« Back to Dashboard

NDA 074286 describes TOPICORT, which is a drug marketed by Taro and is included in ten NDAs. It is available from three suppliers. There are three patents protecting this drug and one Paragraph IV challenge. Additional details are available on the TOPICORT profile page.

The generic ingredient in TOPICORT is desoximetasone. There are seven drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the desoximetasone profile page.

Summary for 074286

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)

Pharmacology for NDA: 074286

Medical Subject Heading (MeSH) Categories for 074286

Suppliers and Packaging for NDA: 074286

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TOPICORT desoximetasone OINTMENT;TOPICAL 074286 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-1262 51672-1262-1 1 TUBE in 1 CARTON (51672-1262-1) > 15 g in 1 TUBE
TOPICORT desoximetasone OINTMENT;TOPICAL 074286 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-1262 51672-1262-7 1 TUBE in 1 CARTON (51672-1262-7) > 100 g in 1 TUBE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;TOPICALStrength0.25%
Approval Date:Jun 7, 1996TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Fuji
Johnson and Johnson
Mallinckrodt
Novartis
Cantor Fitzgerald
Teva
Deloitte
Federal Trade Commission
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot